title: Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients?
authors.forename: Felicetto
authors.initials: F
authors.lastname: Ferrara
authors.forename: Pellegrino
authors.initials: P
authors.lastname: Musto
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic; D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine